One of the main challenges in studying reversibility is the variability in individual responses due to genetic and environmental factors. Additionally, the lack of reliable biomarkers to predict reversibility and the difficulty in simulating human exposure scenarios in animal models add complexity to research efforts. Advancements in omics technologies and improved experimental models are helping to address some of these challenges.
